Prescription Drug Reimportation Opponents, Supporters Discuss Issue At PhRMA Briefing
A congressional staff briefing on Monday by the Pharmaceutical Research and Manufacturers of America addressed drug reimportation "in anticipation that lawmakers will try to legalize low-cost drug purchases from abroad by attaching it to must-pass legislation," CongressDaily reports.
At the briefing, titled "Know the Threat Behind Importation," Peter Pitts, president of the Center for Medicine in the Public Interest and a former FDA associate commissioner, criticized a bill sponsored by Reps. Rahm Emanuel (D-Ill.) and Jo Ann Emerson (R-Mo.) and Sens. Byron Dorgan (D-N.D.) and Olympia Snowe (R-Maine) that would allow reimportation from certain nations.
28 Jun 2007